T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Jack in the Box
JACK
$335M
| $3.62M | ﹤0.01% |
37,218
-6,507
| -15% | -$679K |
|
|
LNW
1552
DELISTED
Light & Wonder
LNW
| $3.6M | ﹤0.01% |
43,345
+6,015
| +16% | +$424K |
|
1553
Macy's
M
$6.2B
| $3.6M | ﹤0.01% |
159,263
-2,486
| -2% | -$49.7K |
|
|
SYNH
1554
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.56M | ﹤0.01% |
40,751
+1,718
| +4% | +$156K |
|
1555
Tenet Healthcare
THC
$21.5B
| $3.54M | ﹤0.01% |
53,303
-4,947
| -8% | -$351K |
|
1556
Concentrix
CNXC
$1.55B
| $3.54M | ﹤0.01% |
19,992
-990
| -5% | -$164K |
|
1557
STAG Industrial
STAG
$7.13B
| $3.51M | ﹤0.01% |
89,508
-11,988
| -12% | -$490K |
|
1558
Aecom
ACM
$8.19B
| $3.5M | ﹤0.01% |
55,480
-5,258
| -9% | -$335K |
|
|
Y
1559
DELISTED
Alleghany Corp
Y
| $3.48M | ﹤0.01% |
5,577
-64
| -1% | -$42.3K |
|
1560
Universal Display
OLED
$4.11B
| $3.48M | ﹤0.01% |
20,355
-710
| -3% | -$147K |
|
1561
MasTec
MTZ
$23.6B
| $3.47M | ﹤0.01% |
40,193
-1,260
| -3% | -$120K |
|
1562
Pricesmart
PSMT
$5.51B
| $3.43M | ﹤0.01% |
44,190
| – | – |
|
1563
HNI Corp
HNI
$3.55B
| $3.42M | ﹤0.01% |
93,272
-1,708
| -2% | -$66.1K |
|
1564
iShares Russell 1000 ETF
IWB
$50.4B
| $3.42M | ﹤0.01% |
14,136
| – | – |
|
1565
Polaris
PII
$3.92B
| $3.41M | ﹤0.01% |
28,508
-1,786
| -6% | -$227K |
|
1566
Jefferies Financial Group
JEF
$12.7B
| $3.39M | ﹤0.01% |
95,518
+7,726
| +9% | +$259K |
|
1567
Old Republic International
ORI
$10.3B
| $3.39M | ﹤0.01% |
146,595
-25,374
| -15% | -$628K |
|
1568
Ginkgo Bioworks
DNA
$469M
| $3.38M | ﹤0.01% |
+7,298
| New | +$3.55M |
|
1569
New York Times
NYT
$10.5B
| $3.37M | ﹤0.01% |
68,485
-753
| -1% | -$35.6K |
|
1570
CytomX Therapeutics
CTMX
$721M
| $3.37M | ﹤0.01% |
662,665
-25,659
| -4% | -$137K |
|
|
MGP
1571
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $3.37M | ﹤0.01% |
88,026
-6,293
| -7% | -$247K |
|
1572
AptarGroup
ATR
$8.38B
| $3.35M | ﹤0.01% |
28,071
+817
| +3% | +$107K |
|
1573
PagerDuty
PD
$923M
| $3.31M | ﹤0.01% |
79,861
-7,706,301
| -99% | -$327M |
|
1574
First Citizens BancShares
FCNCA
$25.8B
| $3.3M | ﹤0.01% |
3,914
-87
| -2% | -$72.3K |
|
1575
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $3.29M | ﹤0.01% |
29,058
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.